The global Neuropathic Pain Market is on an upward trajectory that is hard to ignore. Projected to reach approximately USD 16.62 billion by 2035, the market is anticipated to grow at a compound annual growth rate (CAGR) of 5.19%. This growth is a response to the rising prevalence of conditions such as diabetic neuropathy, which alone accounts for a significant share of the market. As the global...